Patents by Inventor Hamed ALBALAWI

Hamed ALBALAWI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240261465
    Abstract: The present disclosure relates generally to a method of stopping bleeding comprising applying a peptide-based hemostatic material to a bleeding wound, wherein the peptide-based hemostatic material comprises at least one self-assembling ultrashort peptide, and wherein an application of the peptide-based hemostatic material to the bleeding wound produces a coagulation time of less than 40 seconds. The present disclosure also provides a hand-held device for the application of the peptide-based hemostatic material.
    Type: Application
    Filed: June 3, 2022
    Publication date: August 8, 2024
    Inventors: Sherin ABDELRAHMAN, Hamed ALBALAWI, Salwa Ahmed ALSHERI, Charlotte A.E. HAUSER
  • Patent number: 11994520
    Abstract: The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: May 28, 2024
    Assignee: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Charlotte A. E. Hauser, Panagiotis Bilalis, Dana Alhattab, Hepi Hari Susapto, Manola Moretti, Salwa Alshehri, Ali Aldoukhi, Hamed Albalawi, Hattan Boshah, Abdulelah Alrashoudi, Alexander Valle Perez, Rosario Perez Pedroza
  • Publication number: 20230408518
    Abstract: The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.
    Type: Application
    Filed: November 22, 2021
    Publication date: December 21, 2023
    Inventors: Charlotte A.E. Hauser, Panagiotis Bilalis, Dana Alhattab, Hepi Hari Susapto, Manola Moretti, Salwa Alshehri, Ali Aldoukhi, Hamed Albalawi, Hattan Boshah, Abdulelah Alrashoud, Alexander Valle Perez, Rosario Perez Pedroza
  • Publication number: 20230405881
    Abstract: A modified approach for coral restoration by merging 3D printing and molding techniques is presented. This is achieved by 3D scanning live coral specimens, retrieved from sea dives, to obtain a CAD model of the complete coral 3D construction with complex geometries. Select areas of the model are flattened to create a 2D base for micro-fragment adhesion. From the CAD models, disclosed embodiments propose two methods of fabrication. Method A consists of 3D printing the CAD models with commercial thermoplastic materials to create a negative mold, subsequently loaded with synthesized Calcium Carbonate Photoinitiated (CCP) ink to form an eco-friendly coral skeleton. Method B uses syringe-based extrusion 3D printing to directly print a coral skeleton with CCP ink. Both methods are evaluated as a combined proof-of-concept process, 3D CoraPrint, for coral gardening and restoration and providing details required for mimicking coral and bone 3D structures for implantation in bone grafting applications.
    Type: Application
    Filed: June 16, 2023
    Publication date: December 21, 2023
    Inventors: Hamed ALBALAWI, Panagiotis BILALIS, Charlotte A.E. HAUSER